Misfolded proteins destined for the cell surface are recognized and degraded by the ERAD [ER (endoplasmic reticulum) associated degradation] pathway. TS (temperature-sensitive) mutants at the permissive temperature escape ERAD and reach the cell surface. In this present paper, we examined a TS mutant of the CFTR [CF (cystic fibrosis) transmembrane conductance regulator], CFTR ΔF508, and analysed its cell-surface trafficking after rescue [rΔF508 (rescued ΔF508) CFTR]. We show that rΔF508 CFTR endocytosis is 6-fold more rapid (∼30% per 2.5 min) than WT (wild-type, ∼5% per 2.5 min) CFTR at 37 °C in polarized airway epithelial cells (CFBE41o−). We also investigated rΔF508 CFTR endocytosis under two further conditions: in culture at the permissive temperature (27 °C) and following treatment with pharmacological chaperones. At low temperature, rΔF508 CFTR endocytosis slowed to WT rates (20% per 10 min), indicating that the cell-surface trafficking defect of rΔF508 CFTR is TS. Furthermore, rΔF508 CFTR is stabilized at the lower temperature; its half-life increases from <2 h at 37 °C to >8 h at 27 °C. Pharmacological chaperone treatment at 37 °C corrected the rΔF508 CFTR internalization defect, slowing endocytosis from ∼30% per 2.5 min to ∼5% per 2.5 min, and doubled ΔF508 surface half-life from 2 to 4 h. These effects are ΔF508 CFTR-specific, as pharmacological chaperones did not affect WT CFTR or transferrin receptor internalization rates. The results indicate that small molecular correctors may reproduce the effect of incubation at the permissive temperature, not only by rescuing ΔF508 CFTR from ERAD, but also by enhancing its cell-surface stability.
Skip Nav Destination
Article navigation
March 2008
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
February 27 2008
Enhanced cell-surface stability of rescued ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) by pharmacological chaperones
Karoly Varga;
Karoly Varga
1
*Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A
†The Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
Search for other works by this author on:
Rebecca F. Goldstein;
Rebecca F. Goldstein
1
*Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A
†The Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
Search for other works by this author on:
Asta Jurkuvenaite;
Asta Jurkuvenaite
*Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A
†The Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
Search for other works by this author on:
Lan Chen;
Lan Chen
†The Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
‡Department of Anesthesiology, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A
Search for other works by this author on:
Sadis Matalon;
Sadis Matalon
†The Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
‡Department of Anesthesiology, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A
Search for other works by this author on:
Eric J. Sorscher;
Eric J. Sorscher
†The Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
§Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
Search for other works by this author on:
Zsuzsa Bebok;
Zsuzsa Bebok
*Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A
†The Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
Search for other works by this author on:
James F. Collawn
James F. Collawn
2
*Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A
†The Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A.
2To whom correspondence should be addressed (email jcollawn@uab.edu).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
October 15 2007
Revision Received:
November 20 2007
Accepted:
December 04 2007
Accepted Manuscript online:
December 04 2007
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2008 Biochemical Society
2008
Biochem J (2008) 410 (3): 555–564.
Article history
Received:
October 15 2007
Revision Received:
November 20 2007
Accepted:
December 04 2007
Accepted Manuscript online:
December 04 2007
Citation
Karoly Varga, Rebecca F. Goldstein, Asta Jurkuvenaite, Lan Chen, Sadis Matalon, Eric J. Sorscher, Zsuzsa Bebok, James F. Collawn; Enhanced cell-surface stability of rescued ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) by pharmacological chaperones. Biochem J 15 March 2008; 410 (3): 555–564. doi: https://doi.org/10.1042/BJ20071420
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.